Over the past three months, shares of Danaos (NYSE:DAC) fell by 15.24%. Before having a look at the importance of debt, let us look at how much debt Danaos has.
Danaos (NYSE:DAC) reported quarterly earnings of $5.32 per share which beat the analyst consensus estimate of $3.82 by 39.27 percent. This is a 178.53 percent increase over earnings of $1.91 per share from the same
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.